DashboardPortfolio'sControlelijstGemeenschapOntdekScreener
NOT FOR DISTRIBUTION
Loading...
  • Aandelen
  • /
  • Materialen
1d geleden bijgewerkt
CBT logo

Cabot CorporationNYSE:CBT Voorraadrapport

Marktkapitalisatie US$4.2b
1d geleden bijgewerkt
Prijs aandeel
n/a
1Y1.7%
7D-1.4%
1D-1.9%
Portefeuillewaarde
​
Bekijk

Cabot Corporation

NYSE:CBT Voorraadrapport

Marktkapitalisatie: US$4.2b

  • Bedrijfsoverzicht
    • Waardering
    • Toekomstige groei
    • Prestaties in het verleden
    • Financiële gezondheid
    • Dividend
  • Beheer
  • Eigendom
  • Andere informatie
  • Aandelencommunity

Cabot (CBT) Aandelenoverzicht

Cabot Corporation is een bedrijf dat zich bezighoudt met specialistische chemicaliën en hoogwaardige materialen. Meer informatie

CBT fundamentele analyse
Sneeuwvlok Score
Waardering4/6
Toekomstige groei4/6
Prestaties in het verleden2/6
Financiële gezondheid5/6
Dividenden5/6

Beloningen

Verhandeld tegen 9.6% onder onze schatting van de reële waarde

De winst zal naar verwachting met 57.84% per jaar groeien

Betaalt een betrouwbaar dividend van 2.39%

Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

Winstmarges (5.1%) zijn lager dan vorig jaar (11%)

Heeft een hoog schuldenniveau


CBT Community Fair Values

Create Narrative

See what 28 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
10.5% ondergewaardeerd intrinsieke korting
AnalystConsensusTarget
•2mo ago

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

69
0
1
AN
AnalystLowTarget
1.5% overgewaardeerd intrinsieke korting
AnalystLowTarget
•1mo ago

Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential

5
0
0
AN
AnalystHighTarget
22.4% ondergewaardeerd intrinsieke korting
AnalystHighTarget
•2mo ago

Battery And Data Center Demand Will Drive Long-Term Upside Potential

8
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
10.5% ondergewaardeerd intrinsieke korting
AnalystConsensusTarget
•2mo ago

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

69
0
1
AN
AnalystLowTarget
1.5% overgewaardeerd intrinsieke korting
AnalystLowTarget
•1mo ago

Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential

5
0
0
AN
AnalystHighTarget
22.4% ondergewaardeerd intrinsieke korting
AnalystHighTarget
•2mo ago

Battery And Data Center Demand Will Drive Long-Term Upside Potential

8
0
0
View all narratives

Cabot Corporation Concurrenten

Hawkins

Symbol: NasdaqGS:HWKN
Market cap: US$2.5b

Ecovyst

Symbol: NYSE:ECVT
Market cap: US$1.1b

Westlake Chemical Partners

Symbol: NYSE:WLKP
Market cap: US$757.1m

Mativ Holdings

Symbol: NYSE:MATV
Market cap: US$651.8m

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor Cabot
Historische aandelenkoersen
Huidige aandelenkoersUS$79.20
52 Week HoogtepuntUS$94.53
52 Week LaagUS$58.33
Bèta0.83
1 maand verandering-9.88%
3 maanden verandering-10.46%
1 Jaar Verandering1.66%
3 jaar verandering14.43%
5 jaar verandering64.62%
Verandering sinds IPO4,452.82%

Recent nieuws en updates

User avatar
Narratiefupdate • Aug 16

CBT: Rising Carbon Black Concerns Will Drive A Weaker Future Profile

Cabot's analyst price target has moved up from $70.37 to $78.00, with analysts pointing to updated views on revenue growth, profitability, and P/E assumptions following recent research that includes higher price objectives of $90 and $100, along with positive commentary on the battery materials and Performance Chemicals businesses. Analyst Commentary Recent research on Cabot has centered on how the stock trades relative to its P/E assumptions and perceived growth potential in key businesses such as battery materials and Performance Chemicals.

Recent updates

User avatar
Narratiefupdate • Aug 16

CBT: Rising Carbon Black Concerns Will Drive A Weaker Future Profile

Cabot's analyst price target has moved up from $70.37 to $78.00, with analysts pointing to updated views on revenue growth, profitability, and P/E assumptions following recent research that includes higher price objectives of $90 and $100, along with positive commentary on the battery materials and Performance Chemicals businesses. Analyst Commentary Recent research on Cabot has centered on how the stock trades relative to its P/E assumptions and perceived growth potential in key businesses such as battery materials and Performance Chemicals.
Seeking Alpha • Aug 04

Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)

Summary Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT’s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures. Future growth hinges on recovery in reinforcement materials and continued strength in performance chemicals, but macro risks constrain further upside. Read the full article on Seeking Alpha
User avatar
Nieuw narratief • Aug 02

Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential

Catalysts About Cabot Cabot Corporation produces specialty chemicals and materials including reinforcement materials, performance chemicals and battery materials that serve a range of industrial and energy storage applications. What are the underlying business or industry changes driving this perspective?
User avatar
Narratiefupdate • Jun 26

CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook

Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
User avatar
Nieuw narratief • Jun 23

Battery And Data Center Demand Will Drive Long-Term Upside Potential

Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?
Analyse-artikel • Jun 21

Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating

Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...
User avatar
Nieuw narratief • Jun 09

Battery And Data Center Demand Will Support A Steady Long Term Materials Story

Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?
Analyse-artikel • Nov 03

Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?

While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...
Analyse-artikel • Sep 11

Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch

With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...
Analyse-artikel • Jul 20

Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?

Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...
Analyse-artikel • Jun 23

Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...
Analyse-artikel • Apr 25

These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyse-artikel • Apr 10

Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price

Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...
Analyse-artikel • Mar 12

A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price

Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...
Seeking Alpha • Feb 13

Cabot Corporation: Reinforcing Positive Shareholder Value

Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking Alpha
Seeking Alpha • Jan 30

Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)

Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking Alpha
Analyse-artikel • Jan 29

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...
Analyse-artikel • Jan 15

Is Cabot (NYSE:CBT) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analyse-artikel • Jan 02

Returns On Capital Are A Standout For Cabot (NYSE:CBT)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analyse-artikel • Dec 06

Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...
Seeking Alpha • Nov 14

Cabot: Less Than 5% Annualized Upside

Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking Alpha
Analyse-artikel • Oct 31

Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analyse-artikel • Oct 19

Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?

Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...

Rendement voor aandeelhouders

CBTUS ChemicalsUS Markt
7D-1.4%-2.4%-1.6%
1Y1.7%3.3%12.1%

Rendement versus industrie: CBT kwam overeen met de US Chemicals industrie, die het afgelopen jaar een rendement opleverde van 3.3 %.

Rendement versus markt: CBT presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 12.1 % opleverde.

Prijsvolatiliteit

Is CBT's price volatile compared to industry and market?
CBT volatility
CBT Average Weekly Movement5.0%
Chemicals Industry Average Movement5.5%
Market Average Movement6.8%
10% most volatile stocks in US Market15.2%
10% least volatile stocks in US Market2.9%

Stabiele aandelenkoers: CBT heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de US markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van CBT is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
18824,064Sean Keohanewww.cabotcorp.com

Cabot Corporation is een bedrijf dat zich bezighoudt met specialistische chemicaliën en hoogwaardige materialen. Het bedrijf opereert via twee segmenten, Reinforcement Materials en Performance Chemicals. Het bedrijf biedt versterkende koolstoffen die worden gebruikt in banden als een rubberversterkend middel en prestatie-additief, evenals in industriële producten, zoals slangen, riemen, geëxtrudeerde profielen en gegoten goederen; en technische elastomeer composietoplossingen.

Cabot Corporation Samenvatting

Hoe verhouden de winst en inkomsten van Cabot zich tot de beurswaarde?
CBT fundamentele statistieken
MarktkapitalisatieUS$4.17b
Inkomsten(TTM)US$187.00m
Inkomsten(TTM)US$3.63b
21.9x
Koers/Winstverhouding
1.1x
P/S-verhouding

Is CBT overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
CBT resultatenrekening (TTM)
InkomstenUS$3.63b
Kosten van inkomstenUS$2.75b
BrutowinstUS$880.00m
Overige uitgavenUS$693.00m
InkomstenUS$187.00m

Laatst gerapporteerde inkomsten

Jun 30, 2026

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)3.62
Brutomarge24.22%
Nettowinstmarge5.15%
Schuld/Eigen Vermogen Verhouding74.4%

Hoe presteerde CBT op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

2.4%
Huidig dividendrendement
51%
Uitbetalingsratio

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/09/15 13:33
Aandelenkoers aan het einde van de dag2026/09/15 00:00
Inkomsten2026/06/30
Jaarlijkse inkomsten2025/09/30

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
  • SEC-formulier 10-K
  • SEC-formulier 10-Q
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
  • Onderzoeksrapporten van analisten
  • Blue Matrix
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
  • ICE Marktgegevens
  • SEC-formulier S-1
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
  • SEC-formulier 4
  • SEC-formulier 13D
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
  • SEC-formulier 10-K
  • SEC-formulier DEF 14A
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen
  • SEC-formulier 8-K

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Cabot Corporation wordt gevolgd door 11 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Benjamin KalloBaird
Michael LeitheadBarclays
David BegleiterDeutsche Bank

Neem overal betere beleggingsbeslissingen

Scan om te downloaden
Open App StoreGoogle Play openen
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Gegevensbronnen bekijken
Markten
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Beleggingsideeën
  • Ondergewaardeerde bedrijven
  • Dividendkrachtpatsers
  • Kopen met voorkennis
  • Kernenergie
  • Autonome voertuigen
  • Kunstmatige intelligentie
  • Crypto en blockchain
  • Cyberbeveiliging
  • Meer ideeën
Voorraad Gemeenschappen
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Functies en gereedschappen
  • Portfolio Volger
  • Aandelen screener & waarschuwingen
  • Diverse en eerlijke waarden
  • Dividend berekenen
Nieuws & Ontdekkingen
  • Laatste voorraadnieuws
  • Globale markt Inzichten
  • De Foxhole
  • Beleggingsideeën
  • Community nominale waarden
  • Nieuw
Simply Wall St
  • Plannen en prijzen
  • Adverteren
  • Over ons
  • Neem contact met ons op
  • Carrière
  • Helpcentrum
  • Leren beleggen in aandelen
  • Affiliate programma
  • Bedrijf & Onderneming
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Algemene voorwaarden
  • Privacybeleid
  • AI-voorwaarden
  • Gids voor financiële diensten